ovarian cancer patient case report

Case report: The patient was a 55-year-old woman with advanced recurrent epithelial ovarian cancer. The disease course was essentially unremitting with only 5 months of non-progression after initial treatment.

Full Answer

Should we follow-up patients with CA125 After primary therapy of ovarian cancer?

Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed. Ann Oncol. 2011;22(Suppl 8):viii45–viii48. doi: 10.1093/annonc/mdr471.

What is the prognosis of ovarian cancer?

Ovarian cancer has few subjective symptoms, so approximately 40%–50% of cases have already reached stage III or IV by the time of diagnosis. These are advanced stages of the disease and have poor prognosis. Among these cases, less than 3 % are reported to exhibit inguinal lymph node metastasis.

What are the treatment options for ovarian cancer?

However, the disease was well-controlled using various treatments, including neoadjuvant chemotherapy, interval cytoreductive surgery and post-operative long-term chemotherapy. Management of ovarian cancer is most effective when tailored to the individual needs of the patient, maximizing its efficacy and prolonging the patient's survival rate.

Is there a role for management of Stage IV ovarian cancer?

Management of ovarian cancer is most effective when tailored to the individual needs of the patient, maximizing its efficacy and prolonging the patient's survival rate. The present case may offer useful insight into the clinical management of stage IV ovarian cancer

How old was Janice when she was diagnosed with ovarian cancer?

Janice. At 38 years old, Janice was diagnosed with Stage IIIC ovarian cancer and underwent successful surgery followed by 6 cycles of chemotherapy with carboplatin and taxol.

When did Janice's cancer recur?

Because the recurrence again appeared to be localized, in July 2002, Janice underwent tertiary debulking surgery, with successful removal of ...

What drug was used to treat Janice's tumor?

Consequently, a different chemotherapy drug (Gemcitabine) was chosen for the third round of treatment.

When did Janice get her last chemotherapy?

Janice completed her last round of chemotherapy in December of 2002 and today remains cancer-free. Case Highlights: Use of combined PET/CT to diagnose occult recurrence. Use of secondary debulking surgery. Most patients only will be given the option of additional chemotherapy.